Virtual care with remote automated monitoring
Combination ProductUse of Cloud Diagnostics connected health kit for at home monitoring with virtual clinical from nursing and perioperative physician team.
NCT Number: NCT04876950
The Post discharge after surgery Virtual Care with Remote Automated Monitoring technology-2 (PVC-RAM-2) Trial is a multicentre, parallel group, superiority, randomized controlled trial to determine the effect of virtual care with remote automated monitoring (RAM) technology compared to standard care on acute-hospital care during the 45-day follow up after randomization, in adults who have undergone semi-urgent (e.g., oncology), urgent (e.g., hip fracture), or emergency (e.g., ruptured abdominal aortic aneurysm) surgery. Secondary outcomes at 45 days after randomization include 1) days in hospital; 2) index length of hospital stay; 3) hospital re-admission; 4) emergency department visit; 5) medication error detection; 6) medication error correction; and 7) surgical site infection. Additional secondary outcomes are pain of any severity, and moderate-to-severe pain assessed at 15 and 45 days. We will also assess optimal management of long-term health by evaluating among self-reported current smokers and those with atherosclerotic disease, whether patients are taking classes of efficacious medications at 45 days post randomization.
Interested in participating?
Request Info40 year and older
All sexes
Interventional
Not applicable
Hamilton General Hospital, Hamilton, Ontario, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use of Cloud Diagnostics connected health kit for at home monitoring with virtual clinical from nursing and perioperative physician team.
Time frame: 45 days post randomization
Composite outcome of hospital re-admission and emergency department visit, which includes urgent-care centre visit.
Time frame: 45 days post randomization
Total number of days in hospital from randomization to 45 days post-randomization, including index hospital stay and any hospital readmission (s). A day in hospital is counted if a participant spends 1 minute of any day admitted to hospital.
Time frame: 45 days post randomization
Length of hospital stay calculated from time of surgery completion (i.e., time of surgical wound closure) until discharge from the index hospitalization (measured in days and hours).
Time frame: 45 days post randomization
Patient admission to an acute-care hospital.
Time frame: 45 days post randomization
Patient visit to an emergency department.
Time frame: 45 days post randomization
Medication errors include mistakes in medication prescribing, transcribing, dispensing, administering, or monitoring due to preventable events or actions taken by a patient, caregiver, or healthcare worker. Medication errors include: drug omission (i.e., patient did not take a drug they were supposed to take), drug commission (i.e., patient taking a drug they were not supposed to take), duration error, dosing error, frequency error, route error, and timing error. We will record all drug errors identified and also report whether they resulted in harm.
Time frame: 45 days post randomization
Any medication error that is corrected.
Time frame: 45 days post randomization
Surgical site infection is an infection that occurs within 30 days after randomization and involves the skin, subcutaneous tissue of the incision (superficial incisional), or the deep soft tissue (e.g., fascia, muscle) of the incision (deep incisional).
Time frame: 15 and 45 days post randomization
Pain intensity and related interference with usual daily activities, will be measured via the Brief Pain Inventory-Short Form (BPI-SF).The BPI-SF includes four 11-point numeric rating scales (NRS) of pain intensity, which measure "average", "least", and "worst" pain intensity in the past 24 hours (hrs.), respectively, as well as pain intensity "now" (0= no pain, 10= pain as bad as you can imagine).
Time frame: 15 and 45 days post randomization
Pain intensity and related interference with usual daily activities, will be measured via the Brief Pain Inventory-Short Form (BPI-SF).The BPI-SF includes four 11-point numeric rating scales (NRS) of pain intensity, which measure "average", "least", and "worst" pain intensity in the past 24 hours (hrs.), respectively, as well as pain intensity "now" (0= no pain, 10= pain as bad as you can imagine). Pain is of moderate or greater severity is defined by a score of ≥4/10 on a standard numeric rating scale (NRS) for pain.
Time frame: 45 days post randomization
Among patients with atherosclerotic disease, we will also assess optimal pharmacological management based upon whether patients are taking 0, 1, 2, or 3 of the following classes of efficacious medications at 45 days (i.e., an antiplatelet or anticoagulant drug; an angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker; and a statin).
Time frame: 45 days post randomization
Among patient who self-report to be current smokers at baseline, we will assess if patients are receiving pharmacological smoking cessation interventions at 45 days after randomization.
Time frame: 45 days post randomization
Infection is defined as a pathologic process caused by the invasion of normally sterile tissue, fluid, or body cavity by pathogenic or potentially pathogenic organisms.
Time frame: 45 days post randomization
Re-operation refers to any surgical procedure undertaken for any reason (e.g., wound dehiscence, infection).
Time frame: 45 days post randomization
4th Universal definition of myocardial infarction.
Time frame: 45 days post randomization
The definition of acute heart failure requires at least one of the following clinical signs (i.e., elevated jugular venous pressure, respiratory rales or crackles, crepitations, or presence of S3) with at least one of the following:
Time frame: 45 days post randomization
Any arrhythmia that results in patient presenting to an emergency department, which includes an urgent care centre, or being admitted to hospital.
Time frame: 30 days post randomization
All cause mortality.
Time frame: 45 days post randomization
HRQL will be measured with the EuroQol-5 Dimensions-5 Levels (EQ-5D-5L) instrument (https://euroqol.org/eq-5d-instruments/sample-demo) due to its increased sensitivity and validation in several countries including Canada. The EQ-5D-5L is also recommended in Canada to calculate the Quality Adjusted Life Years (QALYs) when conducting cost-effectiveness analyses.
The EQ-5D-5L questionnaire consists of descriptive questions regarding 5 dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), with a 5-level scale for participants to indicate the most accurate response (ranging from no problems to extreme problems).
Time frame: 45 days post randomization
Costs associated with hospital re-admission, length of stay, and healthcare utilization will be obtained from administrative datasets.
Contact information is provided by the study sponsor or research team.
Stephanie Harrison
CONTACT
Valerie Harvey
CONTACT
Population Health Research Institute
Other
Acronym: PVC-RAM-2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04266574
Perioperative Complication, Surgery
Rozzano, Milan, Italy
View Trial DetailsNCT04602429
Abdomen, Acute, Abdominal Pain
Nottingham, United Kingdom
View Trial DetailsNCT04344665
COVID, Perioperative Complication
Edmonton, Alberta, Canada
View Trial DetailsNCT06848751
Lung Function Decreased, Respiration Disorders
Jinan, Shandong, China
View Trial Details